Dianthus Therapeutics, Inc. · NASDAQ:DNTH

Point72 Asset Management, L.P. reported a 5.30% stake in Dianthus Therapeutics, Inc. (Schedule 13G)

Event Sep 11, 2025 · Filed Sep 12, 2025

Point72 Asset Management, L.P. reported a 5.30% stake in Dianthus Therapeutics, Inc., 2,121,140 shares, as a passive investor on Sep 11, 2025. Filed Sep 12, 2025 (Schedule 13G).

Stake
5.30%
Shares
2,121,140
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.5.30%2,121,140
Point72 Capital Advisors, Inc.5.30%2,121,140
Steven A. Cohen5.30%2,121,140

Source

View original at SEC

Related